Safety and efficacy of controlled-release oxycodone: A systematic literature review
被引:30
作者:
Rischitelli, DG
论文数: 0引用数: 0
h-index: 0
机构:Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA
Rischitelli, DG
Karbowicz, SH
论文数: 0引用数: 0
h-index: 0
机构:Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA
Karbowicz, SH
机构:
[1] Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Pharm Serv, Portland, OR 97201 USA
[3] Regence Bluecross Blueshield, Portland, OR USA
来源:
PHARMACOTHERAPY
|
2002年
/
22卷
/
07期
关键词:
D O I:
10.1592/phco.22.11.898.33628
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Prescriptions for controlled-release oxycodone. a narcotic analgesic, recently contributed to a dramatic increase in pharmacy costs for a large private insurance company To determine whether this agent offered clinical benefits over other available drugs that would justify its significantly greater cost, a systematic review of 16 clinical trials was undertaken. The review suggested that immediate-release and controlled-release preparations of oxycodone have similar efficacy and comparable side effect profiles. Controlled-release oxycodone has the advantage of less frequent dosing than immediate-release oxycodone however, other agents may be dosed infrequently at much lower costs. For patients requiring a controlled-release opioid treatment, controlled-release morphine and methadone should be considered because they appear to be as effective as oxycodone and cost considerably less. controlled-release oxycodone may be appropriate for some patients, particularly if they cannot tolerate other controlled-release or long-acting opioid analgesics.